Latest S-1 registration statements

Reborn Coffee is registering for resale up to 3,172,948 shares of its common stock by selling securityholders, including shares issuable under a Standby Equity Purchase Agreement (SEPA) and convertible notes.

Tianci International, a global logistics services provider, files an amendment to its S-1 registration statement for a proposed public offering of common stock, seeking a Nasdaq listing.

Danam Health, Inc. files an amendment to its Form S-1 registration statement, outlining details of its proposed initial public offering and recent acquisitions.

Stryve Foods is undertaking a public offering of Class A Common Stock and pre-funded warrants to raise capital for working capital, general corporate purposes, and debt repayment.

StandardAero, a leading aerospace engine aftermarket service provider, is set to go public, offering 60 million shares with an expected price range of $20 to $23.

FrontView REIT, an internally-managed net-lease REIT focused on outparcel properties, files an amendment to its registration statement for a proposed initial public offering, with plans to list on the NYSE under the symbol FVR.

Grafiti Holding Inc. is pursuing a direct listing on Nasdaq while also working towards a business combination with Damon Motors, a high-performance electric motorcycle company.

Drugs Made In America Acquisition Corp. has filed an amendment to its registration statement for a $500 million initial public offering targeting the pharmaceutical industry.

Cingulate Inc. has filed a registration statement for the resale of up to 1,500,000 shares of its common stock by Lincoln Park Capital Fund, LLC.

Firefly Neuroscience registers for the resale of up to 2.56 million shares of common stock by selling securityholders following its recent reverse merger with WaveDancer.

The Marquie Group, Inc. has filed a registration statement for the resale of up to 5,000,000,000 shares of its common stock by a selling stockholder, while also acknowledging substantial doubt about its ability to continue as a going concern.

Jet.AI files an amendment to its S-1 registration statement for the resale of up to 16,232,232 shares of common stock by a selling stockholder.

Hyperscale Data, Inc. aims to raise up to $25 million by offering 1,500,000 shares of its 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock, primarily to fund debt repayment and working capital.

American Battery Materials aims to raise capital through a public offering to fund the development of its Lisbon Valley Lithium Project and explore further acquisitions.

CAMP4 Therapeutics is planning an initial public offering to fund its regulatory RNA-based therapeutics development.

Guardian Pharmacy Services files a registration statement to increase its Class A common stock offering by 1,437,500 shares, including an underwriter option.

Cloudastructure, a cloud-based AI video surveillance company, files an S-1/A form for a direct listing on Nasdaq, offering warrants and Class A common stock.

Lottery.com Inc. aims to raise $150 million through a primary offering of 50,000,000 shares of common stock, alongside a secondary offering by selling securityholders.

BioAge Labs has filed a registration statement to increase its common stock offering by 575,000 shares, including an underwriter's option, representing no more than 20% of the prior offering's maximum aggregate price.

Banzai International amends its registration statement to revise disclosures related to the potential resale of up to 25 million Class A Common Stock shares by a selling securityholder.

Apimeds Pharmaceuticals US, Inc. has filed an S-1 registration statement for an initial public offering to fund the clinical development of Apitox, a bee venom-based treatment for osteoarthritis and multiple sclerosis.

Edible Garden AG Incorporated is offering up to 8,602,150 units, each consisting of common stock or pre-funded warrants and Class A and B warrants, to raise up to $8 million in a bid to meet Nasdaq's minimum stockholders' equity requirement.

Seelos Therapeutics is seeking to raise capital through a public offering of common stock and warrants to fund general corporate purposes and advance its product pipeline.

BioAge Labs is seeking to raise $180 million through an IPO to fund the development of its pipeline, including azelaprag for metabolic diseases and NLRP3 inhibitors for neuroinflammation.

Invech Holdings, Inc. files an amendment to its S-1 registration statement for the resale of up to 3,277,416 shares of common stock by selling stockholders, with the company not receiving any proceeds from the sale.

Health In Tech, an insurance technology platform, is seeking to raise capital through an initial public offering (IPO) to fund system enhancements, business expansion, and sales growth, aiming for a Nasdaq listing under the symbol HIT.

Charlton Aria Acquisition Corporation, a newly formed blank check company, aims to raise $75 million through an IPO to pursue a merger, share exchange, asset acquisition, or similar business combination across various industries and regions.

Rising Dragon Acquisition Corp., a blank check company, files an amendment to its S-1 registration statement for a $50 million IPO, aiming to merge with businesses in green energy, tech, and healthcare.

Banzai International is filing a prospectus for the resale of shares of Class A Common Stock and warrants by selling securityholders.

FrontView REIT amends its S-11 filing, detailing a share contribution agreement and preparations for its initial public offering.